Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Total 13F shares
-
6,752,518
-
Share change
-
+695,119
-
Total reported value
-
$100,597,635
-
Put/Call ratio
-
83%
-
Price per share
-
$14.90
-
Number of holders
-
58
-
Value change
-
+$11,330,651
-
Number of buys
-
37
-
Number of sells
-
15
Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q3 2021
As of 30 Sep 2021 PDS Biotechnology Corp - Common (PDSB) had 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,752,518 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, AIGH Capital Management LLC, TWO SIGMA ADVISERS, LP, BlackRock Inc., TWO SIGMA INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Invesco Ltd., EAM Investors, LLC, and INSPIRION WEALTH ADVISORS, LLC.
This table shows 58 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.